Starpharma Holdings Limited (SPHRY)
SPHRY Stock Price Chart
Explore Starpharma Holdings Limited interactive price chart. Choose custom timeframes to analyze SPHRY price movements and trends.
SPHRY Company Profile
Discover essential business fundamentals and corporate details for Starpharma Holdings Limited (SPHRY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 May 2007
Employees
40.00
Website
https://starpharma.comCEO
Cheryl Maley
Description
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
SPHRY Financial Timeline
Browse a chronological timeline of Starpharma Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Feb 2026
Earnings released on 20 Aug 2025
Earnings released on 26 Feb 2025
Earnings released on 30 Oct 2024
EPS came in at -$0.01 , while revenue for the quarter reached $1.15M .
Earnings released on 22 May 2024
EPS came in at -$0.00 , while revenue for the quarter reached $4.90M , missing expectations by -49.95%.
Earnings released on 30 Jun 2023
EPS came in at -$0.01 , while revenue for the quarter reached $1.23M .
Earnings released on 31 Dec 2022
EPS came in at -$0.01 , while revenue for the quarter reached $742.17K , missing expectations by -87.10%.
Earnings released on 30 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $1.97M , missing expectations by -5.90%.
Earnings released on 31 Dec 2021
EPS came in at -$0.02 , while revenue for the quarter reached $1.32M .
Earnings released on 30 Jun 2021
EPS came in at -$0.02 , while revenue for the quarter reached $985.03K , missing expectations by -93.32%.
Earnings released on 31 Dec 2020
EPS came in at -$0.02 , while revenue for the quarter reached $372.71K , missing expectations by -87.37%.
SPHRY Stock Performance
Access detailed SPHRY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.